ANOTHER STUDY BRINGS MORE HOPE -- ALPHA S... - Cure Parkinson's

Cure Parkinson's

26,584 members27,904 posts

ANOTHER STUDY BRINGS MORE HOPE -- ALPHA SYNUCLEIN CLUMP REMOVAL

jimcaster profile image
16 Replies

More ENCOURAGING news...

m.medicalxpress.com/news/20...

Written by
jimcaster profile image
jimcaster
To view profiles and participate in discussions please or .
16 Replies
Kia17 profile image
Kia17

Thanks for sharing.

"Our discovery clearly indicates that inhibition of USP13 is a strategic step to activate parkin and counteract alpha-synuclein de-ubiquitination, to increase toxic protein clearance" added Moussa. "Our next step is to develop a small molecule inhibitor of USP13 to be used in combination with nilotinib in order to maximize protein clearance in Parkinson's and other neurodegenerative diseases.Nilotinib is FDA approved for use in specific blood cancers.”

ConnieD profile image
ConnieD in reply toKia17

Hi Kia!! Correct me if I’m wrong but isn’t nilotinib in trial phases for Parkinson’s? I couldn’t open the attachment and do you know if some Drs allow PD patients to try it?

Kia17 profile image
Kia17 in reply toConnieD

Hi Connie ,Nilotinib is considered to be combined with the USP13 for the alpha-synucleun removal but none of them are in trial phase yet. Nilotinib is a medication being used for some special type of CML(Leukaemia) and I donot think any doctor dares to prescribe it for PD without being approved by the FDA for that purpose.

ConnieD profile image
ConnieD in reply toKia17

Thanks Kia for explaining and to Jim for sharing!!😊

Kia17 profile image
Kia17 in reply toConnieD

You’re welcome Connie.

jimcaster profile image
jimcaster in reply toConnieD

google.com/amp/s/parkinsons...

MBAnderson profile image
MBAnderson in reply toConnieD

Connie, I've been taking Nilotinib since 11/1/16 and I know of only one doctor (in upstate New York) who has prescribed it, but he has since stopped. N is in phase II trials.

m.medicalxpress.com/news/20...

ConnieD profile image
ConnieD in reply toMBAnderson

Interesting MB! What symptoms do you find it helpful for? When a drug is in phase 2 how much longer before it could possibly come to market? I know it has to go through phase 3 as well. Thanks, Connie

MBAnderson profile image
MBAnderson in reply toConnieD

Connie,

I cannot attribute any benefit to it because my regime includes a lot of other stuff. However, I had my semiannual visit with my neurologist at the VA a couple weeks ago and he said I had improved since my previous visit and, assuming that is true, I would not attribute all the benefit to N.

There's no telling how long it takes to get to market.

Perhaps phase II trial will end in one year and then 6 to 12 months to publish the data, then 12 to 18 months to organize (secure all approvals) and raise the funding for phase III, which, including time for recruiting, could take 36 months to complete and publish the data then perhaps 18 to 24 months for FDA approval.

Best case scenario 7 years up to perhaps 10 years.

ConnieD profile image
ConnieD in reply toMBAnderson

Thanks that sure is a long time! I’m glad you are able to use it, keep it up you’re doing something right that’s for sure!!😊

Kia17 profile image
Kia17 in reply toMBAnderson

Thank you . I didn’t know that.

kalyan48 profile image
kalyan48 in reply toKia17

correct me if I am wrong , but isn't MANNITOL supposed to clear alpha-synuclein

Kia17 profile image
Kia17 in reply tokalyan48

The study is targeting different substances than Mannitol. It doesn’t discredit Mannitol’s functionality.

kalyan48 profile image
kalyan48 in reply toKia17

Thanks

Xenos profile image
Xenos

Sounds really promising.

Thanks for sharing this.

MBAnderson profile image
MBAnderson

Apparently, Moussa et. al. are not resting on their laurels, nor has forsaken N.

Not what you're looking for?

You may also like...

N-acetylglucosamine (GlcNAc) reduces alpha-synuclein aggregation

"Treating cells with N-acetylglucosamine, a molecule in the hexosamine pathway, improved protein...
NextStage profile image

alpha synuclein, amylin, chatgpt

I found out amylin aggregates in people with diabetes damaging pancreatic beta cells. It appears...
Edge999 profile image

Bacillus subtillus vs Alpha synuclein

Hi everyone, for those that prefer eating supplements as food I have just found out that the Korean...
Getz profile image

Plasma alpha-synuclein PD subtypes, PIGD

The relation between plasma α-synuclein level and clinical symptoms or signs of Parkinson's...

Mechanism by which Alpha synuclein causes neuronal cell death found

https://www.hopkinsmedicine.org/news/newsroom/news-releases/road-to-cell-death-more-clearly-identifi
park_bear profile image

Moderation team

See all
CPT_Aleksandra profile image
CPT_AleksandraAdministrator
CPT_Anaya profile image
CPT_AnayaAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.